Trimarchi Thomas, President and CFO of BridgeBio Pharma ($BBIO), sold about $5.1 million in company shares through seven open market transactions over the last year. His most recent sale occurred on February 17, 2026. These insider sales rank 1905th among 11,678 individuals in our database, compared to an average of $8.6 million per seller across 6.37 transactions. Thomas made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 18, 2026 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | A | Common Stock | 59041 | $0.00 | 395,626.0000 | 192,708,813 | 17.54% | 0.03% |
| Feb. 16, 2026 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | F | Common Stock | 18819 | $75.25 | 350,185.0000 | 192,708,813 | 5.10% | 0.01% |
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | S | Common Stock | 200 | $75.38 | 336,585.0000 | 192,708,813 | 0.06% | 0.00% |
| Feb. 17, 2026 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | S | Common Stock | 13400 | $74.71 | 336,785.0000 | 192,708,813 | 3.83% | 0.01% |
| Dec. 12, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | F | Common Stock | 13826 | $75.15 | 369,004.0000 | 192,708,813 | 3.61% | 0.01% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | S | Common Stock | 9978 | $66.19 | 389,786.0000 | 192,708,813 | 2.50% | 0.01% |
| Nov. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | F | Common Stock | 21317 | $66.39 | 399,764.0000 | 192,708,813 | 5.06% | 0.01% |
| Nov. 17, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | S | Common Stock | 6956 | $66.84 | 382,830.0000 | 192,708,813 | 1.78% | 0.00% |
| Aug. 21, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | S | Common Stock | 42237 | $49.48 | 421,081.0000 | 190,188,626 | 9.12% | 0.02% |
| Aug. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | F | Common Stock | 21317 | $51.32 | 480,671.0000 | 190,188,626 | 4.25% | 0.01% |
| Aug. 18, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | S | Common Stock | 15380 | $50.14 | 465,291.0000 | 190,188,626 | 3.20% | 0.01% |
| Aug. 18, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | S | Common Stock | 1973 | $50.94 | 463,318.0000 | 190,188,626 | 0.42% | 0.00% |
| May 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | F | Common Stock | 21317 | $33.84 | 501,988.0000 | 190,188,626 | 4.07% | 0.01% |
| March 19, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and CFO | A | Common Stock | 109100 | $0.00 | 523,305.0000 | 190,188,626 | 26.34% | 0.06% |
| Feb. 16, 2025 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and COO | F | Common Stock | 13782 | $34.90 | 414,205.0000 | 190,188,626 | 3.22% | 0.01% |
| Dec. 10, 2024 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and COO | A | Common Stock | 50000 | $0.00 | 427,987.0000 | 0 | 13.23% | 0.00% |
| Nov. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and COO | F | Common Stock | 17936 | $23.72 | 377,987.0000 | 0 | 4.53% | 0.00% |
| Aug. 16, 2024 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and COO | F | Common Stock | 17936 | $24.40 | 395,923.0000 | 0 | 4.33% | 0.00% |
| Aug. 6, 2024 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and COO | A | Stock Option (Right to Buy) | 3160 | $0.00 | 3,160.0000 | 0 | 9999.99% | 0.00% |
| Aug. 6, 2024 | BridgeBio Pharma, Inc. | $BBIO | Trimarchi Thomas | President and COO | A | Common Stock | 19003 | $0.00 | 413,859.0000 | 0 | 4.81% | 0.00% |